EPZM logo

Epizyme (EPZM) Cash And Cash Equivalents

EPZM Annual Cash & Cash Equivalents

$98.34 M
-$69.88 M-41.54%

31 December 2021

EPZM Cash And Cash Equivalents Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

EPZM Quarterly Cash And Cash Equivalents

$71.07 M
-$6.36 M-8.21%

30 June 2022

EPZM Quarterly Cash And Cash Equivalents Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

EPZM Cash And Cash Equivalents Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-41.5%-11.3%
3 y3 years+13.5%+54.7%
5 y5 years-56.6%-19.7%

EPZM Cash And Cash Equivalents High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall time-56.6%-77.3%

Epizyme Cash And Cash Equivalents History

DateAnnualQuarterly
June 2022
-
$71.07 M(-8.2%)
Mar 2022
-
$77.42 M(-21.3%)
Dec 2021
$98.34 M(-41.5%)
$98.34 M(-21.0%)
Sept 2021
-
$124.52 M(+55.3%)
June 2021
-
$80.16 M(+8.8%)
Mar 2021
-
$73.71 M(-56.2%)
Dec 2020
$168.22 M(+20.6%)
$168.22 M(+80.1%)
Sept 2020
-
$93.42 M(-20.3%)
June 2020
-
$117.15 M(-34.6%)
Mar 2020
-
$179.26 M(+28.5%)
Dec 2019
$139.48 M(+60.9%)
$139.48 M(+49.2%)
Sept 2019
-
$93.46 M(+103.5%)
June 2019
-
$45.93 M(-68.2%)
Mar 2019
-
$144.31 M(+66.5%)
Dec 2018
$86.67 M(-61.8%)
$86.67 M(+30.8%)
Sept 2018
-
$66.28 M(-2.4%)
June 2018
-
$67.91 M(-47.9%)
Mar 2018
-
$130.29 M(-42.5%)
Dec 2017
$226.66 M
$226.66 M(+3.1%)
Sept 2017
-
$219.79 M(+148.3%)
DateAnnualQuarterly
June 2017
-
$88.53 M(+37.5%)
Mar 2017
-
$64.38 M(-17.3%)
Dec 2016
$77.89 M(-62.6%)
$77.89 M(+18.0%)
Sept 2016
-
$66.03 M(-26.2%)
June 2016
-
$89.48 M(-71.4%)
Mar 2016
-
$312.66 M(+50.1%)
Dec 2015
$208.32 M(+9.6%)
$208.32 M(-9.4%)
Sept 2015
-
$229.94 M(-2.9%)
June 2015
-
$236.69 M(-3.2%)
Mar 2015
-
$244.50 M(+28.6%)
Dec 2014
$190.09 M(+53.8%)
$190.09 M(-10.2%)
Sept 2014
-
$211.67 M(-7.9%)
June 2014
-
$229.87 M(-3.0%)
Mar 2014
-
$237.06 M(+91.9%)
Dec 2013
$123.56 M(+26.1%)
$123.56 M(-11.5%)
Sept 2013
-
$139.57 M(-6.1%)
June 2013
-
$148.69 M(+74.8%)
Mar 2013
-
$85.05 M(-13.2%)
Dec 2012
$97.98 M(+193.9%)
$97.98 M
Dec 2011
$33.34 M
-

FAQ

  • What is Epizyme annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Epizyme?
  • What is Epizyme annual cash & cash equivalents year-on-year change?
  • What is Epizyme quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for Epizyme?
  • What is Epizyme quarterly cash and cash equivalents year-on-year change?

What is Epizyme annual cash & cash equivalents?

The current annual cash & cash equivalents of EPZM is $98.34 M

What is the all time high annual cash & cash equivalents for Epizyme?

Epizyme all-time high annual cash & cash equivalents is $226.66 M

What is Epizyme annual cash & cash equivalents year-on-year change?

Over the past year, EPZM annual cash & cash equivalents has changed by -$69.88 M (-41.54%)

What is Epizyme quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of EPZM is $71.07 M

What is the all time high quarterly cash and cash equivalents for Epizyme?

Epizyme all-time high quarterly cash and cash equivalents is $312.66 M

What is Epizyme quarterly cash and cash equivalents year-on-year change?

Over the past year, EPZM quarterly cash and cash equivalents has changed by -$9.10 M (-11.35%)